会员登录 - 用户注册 - 设为首页 - 加入收藏 - 网站地图 【wood stain with green undertone】Crocs, Shoe Carnival Surge Higher After Susquehanna Upgrades!

【wood stain with green undertone】Crocs, Shoe Carnival Surge Higher After Susquehanna Upgrades

时间:2024-09-29 12:21:29 来源:stickers and banners removable vinyl 作者:Focus 阅读:951次

Thewood stain with green undertone future looks bright for

Shoe Carnival, Inc.

【wood stain with green undertone】Crocs, Shoe Carnival Surge Higher After Susquehanna Upgrades


(NASDAQ:

【wood stain with green undertone】Crocs, Shoe Carnival Surge Higher After Susquehanna Upgrades


SCVL

【wood stain with green undertone】Crocs, Shoe Carnival Surge Higher After Susquehanna Upgrades


) and


Crocs, Inc.


(NASDAQ:


CROX


) heading into 2019, according to Susquehanna.


The Analyst


Analyst Sam Poser upgraded Shoe Carnival from Neutral to Positive with a $42 price target.


Poser upgraded Crocs from Neutral to Positive with a price target lifted from $25 to $31.


Analyst: Shoe Carnival Pullback Unwarranted


With significant improvements in customer engagement and merchandising becoming evident, Poser said to buy


Shoe Carnival


.


Shoe Carnival’s recent double-digit pullback is unwarranted, and the correct levels of more relevant assortments should give the company's results ongoing momentum, the analyst said in the Wednesday upgrade note.


Strong performance


from Shoe Carnival's largest vendor,


Nike Inc


(NYSE:


NKE


), also bodes well for the company, Poser said.


“Given the strong results and improved, yet conservative outlook, we had not anticipated an opportunity to upgrade the company in the near term."


Shoe Carnival shares were up 4.27 percent at $34.94 at the time of publication Wednesday.


Bullish On Crocs


Crocs is a buy following the recent repurchase and conversion of


Blackstone Group LP


(NYSE:


BX


)'s preferred stock position in the company, Poser said.


“The action removes a significant financial overhang from the company’s capital structure/P&L and shifts more control of CROX business into the hands of existing and potential shareholders,” the analyst said.


Susquehanna sees Crocs’ business continuing to accelerate as products improve and the brand gains mindshare through compelling collaborations.


In December, Crocs' second collaboration with hip-hop star Post Malone sold out in seconds and a created a lot buzz in the sneaker and social media worlds.


Crocs shares were up 5.16 percent at $27.32 at the time of publication.


Related Links:


Rhone Looks To Pioneer An Underserved Premium Mens Activewear Category


Study: Nike Is The Top Apparel Brand Among Gen Z, Millennials


Latest Ratings for SCVL


Jan 2019


Susquehanna


Upgrades


Neutral


Positive


Nov 2018


Wedbush


Maintains


Outperform


Outperform


Nov 2018


Pivotal Research


Upgrades


Hold


Buy


View More Analyst Ratings for SCVL


View the Latest Analyst Ratings


See more from Benzinga


8 Stocks Moving In Thursday's After-Hours Session


© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


View comments


(责任编辑:Focus)

相关内容
  • JPMorgan (JPM) Signs Deal to Acquire Fintech Start-up 55ip
  • Miley Cyrus performs as Black Mirror persona Ashley O at Glastonbury Festival
  • In 2022, Only One Thing Will Unite the Global Blockchain Takeover
  • A Look At The Fair Value Of Watkin Jones Plc (LON:WJG)
  • WhatsApp no longer supported on millions of phones
  • BRIEF-Scanwolf Corporation Says Teoh Teik Kean Resigned As Executive Director
  • How Ford Will Cut Its Losses in China
  • The Bank of Commerce Holdings (NASDAQ:BOCH) Share Price Is Up 95% And Shareholders Are Holding On
推荐内容
  • Ingredion Incorporated Reports Third Quarter 2020 Results
  • Those who invested in Fidelity National Information Services (NYSE:FIS) five years ago are up 47%
  • U.S. banks 'well-positioned' to manage adverse market conditions -OCC spokesman
  • Thousands fired after garment industry protest in Bangladesh
  • California ballot initiative on gig workers could be among costliest in state's history
  • Horizon Pharma (HZNP) Up 28% on Business Expansion Strategy